Literature DB >> 25093297

Hypoxia inducible factor-1α suppresses Peroxiredoxin 3 expression to promote proliferation of CCRCC cells.

Hao Xi1, Yao-Hui Gao2, Dong-Yan Han1, Qian-Yu Li1, Li-Jin Feng1, Wei Zhang1, Guo Ji1, Jia-Cheng Xiao1, Hui-Zhen Zhang3, Qing Wei4.   

Abstract

Peroxiredoxin 3 (Prx3) is a mitochondrial member of the antioxidant family of thioredoxin peroxidases that uses mitochondrial thioredoxin 2 as a source of reducing equivalents to scavenge hydrogen peroxide (H2O2). Here, we report that the protein levels of Prx3 are significantly reduced in VHL-deficient clear cell renal cell carcinoma (CCRCC). Furthermore, stabilization of HIF-1α protein, caused either by VHL deficiency under normoxia, or by hypoxia, significantly reduced Prx3 expression. Luciferase-reporter and chromatin-immunoprecipitation assays indicated that HIF-1α binds to the hypoxia-responsive elements of PRDX3 promoter and represses its transcription. Finally, shRNA-based assays suggested that Prx3 downregulation is required for the HIF-1α-dependent proliferation of CCRCC cells. Taken together, our results shed new light onto the mechanism of HIF-1α-dependent proliferation in CCRCC cells.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIF-1α; Proliferation; Prx3; VHL

Mesh:

Substances:

Year:  2014        PMID: 25093297     DOI: 10.1016/j.febslet.2014.07.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.

Authors:  Sherry E Adesina; Brandy E Wade; Kaiser M Bijli; Bum-Yong Kang; Clintoria R Williams; Jing Ma; Young-Mi Go; C Michael Hart; Roy L Sutliff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

2.  The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis.

Authors:  Ruimin Sun; Xinyao Tian; Yang Li; Yan Zhao; Zhecheng Wang; Yan Hu; Lijun Zhang; Yue Wang; Dongyan Gao; Shusen Zheng; Jihong Yao
Journal:  Redox Biol       Date:  2022-06-24       Impact factor: 10.787

3.  The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma

Authors:  Oktay Halit Aktepe; Gürkan Güner; Deniz Can Güven; Taha Koray Şahin; Fadime Sinem Ardıç; Deniz Yüce; Şuayib Yalçın; Mustafa Erman
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

4.  Low oxygen alters mitochondrial function and response to oxidative stress in human neural progenitor cells.

Authors:  Yury M Lages; Juliana M Nascimento; Gabriela A Lemos; Antonio Galina; Leda R Castilho; Stevens K Rehen
Journal:  PeerJ       Date:  2015-12-10       Impact factor: 2.984

Review 5.  Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.

Authors:  Stephen John Ralph; Rhys Pritchard; Sara Rodríguez-Enríquez; Rafael Moreno-Sánchez; Raymond Keith Ralph
Journal:  Pharmaceuticals (Basel)       Date:  2015-02-13

6.  VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.

Authors:  Yao-Hui Gao; Zhao-Xia Wu; Li-Qi Xie; Cai-Xia Li; Yu-Qin Mao; Yan-Tao Duan; Bing Han; San-Feng Han; Yun Yu; Hao-Jie Lu; Peng-Yuan Yang; Tian-Rui Xu; Jing-Lin Xia; Guo-Qiang Chen; Li-Shun Wang
Journal:  Nat Commun       Date:  2017-06-15       Impact factor: 14.919

7.  The role of peroxiredoxins in cancer.

Authors:  Arianna Nicolussi; Sonia D'Inzeo; Carlo Capalbo; Giuseppe Giannini; Anna Coppa
Journal:  Mol Clin Oncol       Date:  2017-01-10

Review 8.  Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.

Authors:  Tayaba Ismail; Youni Kim; Hongchan Lee; Dong-Seok Lee; Hyun-Shik Lee
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

9.  PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia.

Authors:  Weibo Luo; Ivan Chen; Yan Chen; Duah Alkam; Yingfei Wang; Gregg L Semenza
Journal:  Oncotarget       Date:  2016-02-09

Review 10.  Peroxiredoxins in Cancer and Response to Radiation Therapies.

Authors:  Tom E Forshaw; Reetta Holmila; Kimberly J Nelson; Joshua E Lewis; Melissa L Kemp; Allen W Tsang; Leslie B Poole; W Todd Lowther; Cristina M Furdui
Journal:  Antioxidants (Basel)       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.